Patents by Inventor Corina Dutcus

Corina Dutcus has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of Renal Cell Carcinoma with Lenvatinib and Everolimus
    Publication number: 20200375975
    Abstract: Methods for treating a renal cell carcinoma with an improved combination of lenvatinib or a pharmaceutically acceptable salt thereof and everolimus are provided. These methods further comprises adjusting the dosages of lenvatinib during the onset of adverse effects to lead to improved treatment methods for human subjects with renal cell carcinoma. Particularly useful dosages and dose modifications upon the occurrence of adverse events are also provided.
    Type: Application
    Filed: August 19, 2020
    Publication date: December 3, 2020
    Applicant: Eisai R&D Management Co., Ltd.
    Inventors: Alton KREMER, Corina DUTCUS
  • TUMOR THERAPEUTIC AGENT
    Publication number: 20190000797
    Abstract: A novel tumor therapeutic agent for a combination therapy is disclosed. More specifically, a tumor therapeutic agent used for a combination therapy of lenvatinib, ifosfamide, and etoposide is disclosed.
    Type: Application
    Filed: August 18, 2016
    Publication date: January 3, 2019
    Applicant: Eisai R&D Management Co., Ltd.
    Inventors: Kiyoshi Okamoto, Junji Matsui, Corina Dutcus